How Is the Europe Cell and Gene Therapy CDMO Market Set to Surge...

σε πρόσθεσε στο Business

2025-11-19 14:19:14

How Is the Europe Cell and Gene Therapy CDMO Market Set to Surge from USD 371.65 Million in 2018 to USD 3,991.18 Million by 2032 as Advanced Therapies, Biopharma Outsourcing, and Regulatory Support Transform the Region’s Therapeutic Landscape?

Introduction The Europe Cell and Gene Therapy Contract Development and Manufacturing Organization (CDMO) Market has undergone remarkable evolution over the last decade. Valued at USD 371.65 million in 2018, increasing to USD 1,112.23 million in 2024, and projected to rise dramatically to USD 3,991.18 million by 2032, the market is registering a robust CAGR of 16.05% through the forecast period....

0 Σχόλια 2 Μοιράστηκε 282 Views